International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.14 and traded as high as $0.17. International Stem Cell shares last traded at $0.17, with a volume of 7,751 shares changing hands.
International Stem Cell Price Performance
The firm has a fifty day moving average price of $0.15 and a two-hundred day moving average price of $0.14. The stock has a market capitalization of $1.36 million, a P/E ratio of -8.50 and a beta of 0.11.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
See Also
- Five stocks we like better than International Stem Cell
- 3 Small Caps With Big Return Potential
- Why Amazon Could Be a $300 Stock Within Weeks
- Why is the Ex-Dividend Date Significant to Investors?
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- What to Know About Investing in Penny Stocks
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
